Critical role of acetylation in tau-mediated neurodegeneration and cognitive deficits

Min, Sang-Won, Chen, Xu, Tracy, Tara E, Li, Yaqiao, Zhou, Yungui, Wang, Chao, Shirakawa, Kotaro, Minami, S Sakura +14 more·2015·Nature Medicine
DOI 10.1038/nm.3951

Cited by (518)

Items 301–400 of 518

  1. Acetylation and phosphorylation processes modulate Tau’s binding to microtubules: A molecular dynamics study
    Tarsila G. Castro, Tiago Ferreira, Teresa Matamá, Florentina‐Daniela Munteanu, Artur Manuel Cavaco-Paulo · 2022 · Biochimica et Biophysica Acta (BBA) - General Subjects
  2. Chaperone-mediated autophagy in neurodegenerative diseases: mechanisms and therapy
    Yi Liu, Ming Tan, Meng‐Shan Tan · 2023 · Molecular and Cellular Biochemistry
  3. New insights into the therapeutic approaches for the treatment of tauopathies
    Himanshi Singh, Asmita Das, Mohammad Moshahid Khan, Tayebeh Pourmotabbed · 2023 · Neural Regeneration Research
  4. The absence of SIRT3 and SIRT5 promotes the acetylation of lens proteins and improves the chaperone activity of α-crystallin in mouse lenses
    Sandip Kumar Nandi, Rooban B. Nahomi, Peter S. Harris, Cole R. Michel, Kristofer S. Fritz, Ram H. Nagaraj · 2019 · Experimental Eye Research
  5. A genome-wide screen for human salicylic acid (SA)-binding proteins reveals targets through which SA may influence development of various diseases
    Hyong Woo Choi, Lei Wang, Adrian F. Powell, Susan R. Strickler, Dekai Wang, D’Maris Amick Dempsey, Frank C. Schroeder, Daniel F. Klessig · 2019 · Scientific Reports
  6. Pathogenic Tau Protein Species: Promising Therapeutic Targets for Ocular Neurodegenerative Diseases
    Mohammad Amir Mishan, Mozhgan Rezaei Kanavi, Koorosh Shahpasand, Hamid Ahmadieh · 2019 · Journal of Ophthalmic and Vision Research
  7. Smart treatment strategies for alleviating tauopathy and neuroinflammation to improve clinical outcome in Alzheimer's disease
    Katyayani Tatiparti, Samaresh Sau, Mohd Ahmar Rauf, Arun K. Iyer · 2020 · Drug Discovery Today
  8. Reduced ULK1 links impaired autophagy and mitophagy to Alzheimer’s disease pathology
    Jun‐Ping Pan, Ping-Jie Wang, Jianying Zhang, Anne‐Brita Knapskog, Leiv Otto Watne, He-Ling Wang, Mariá José Lagartos-Donate, Sofie Lautrup, Li-Peng Mao, Qian Wang et al. · 2026 · Nature Aging
  9. Tau Acetylation in Entorhinal Cortex Induces its Chronic Hippocampal Propagation and Cognitive Deficits in Mice
    Xin Wang, En-Jie Liu, Qian Rong Liu, Shihong Li, Ting Li, Qiuzhi Zhou, Yanchao Liu, Huaqiu Zhang, Jian‐Zhi Wang · 2020 · Journal of Alzheimer s Disease
  10. Salsalate reverses metabolic disorders in a mouse model of non‐alcoholic fatty liver disease through AMPK activation and caspase‐6 activity inhibition
    Jingjing Li, Changmai Chen, Wei Zhang, Jingai Bi, Guangmin Yang, Erguang Li · 2020 · Basic & Clinical Pharmacology & Toxicology
  11. Regulation of Tau Homeostasis and Toxicity by Acetylation
    Tara E. Tracy, Kathryn C. Claiborn, Li Gan · 2019 · Advances in experimental medicine and biology
  12. The Involvement of Post-Translational Modifications in Regulating the Development and Progression of Alzheimer’s Disease
    Pei-Pei Guan, Pu Wang · 2023 · Molecular Neurobiology
  13. Sowing the Seeds of Discovery: Tau-Propagation Models of Alzheimer’s Disease
    Benjamin J. Bell, Medhinee M. Malvankar, Carolyn Tallon, Barbara Stauch Slusher · 2020 · ACS Chemical Neuroscience
  14. Arsenic and Tau Phosphorylation: A Mechanistic Review
    Ariafar, Saba, Makhdoomi, Sajjad, Mohammadi, Mojdeh · 2023 · Biological Trace Element Research
  15. Drugs repurposing in the experimental models of Alzheimer’s disease
    Sheer A. Joodi, Weam W. Ibrahim, Mahmoud Mohamed Khattab · 2025 · Inflammopharmacology
  16. Disease-modifying strategies in primary tauopathies
    Thomas W. Rösler, Márcia Costa, Günter U. Höglinger · 2019 · Neuropharmacology
  17. Tau mRNA Metabolism in Neurodegenerative Diseases: A Tangle Journey
    Paulo J. da Costa, Malika Hamdane, Luc Buée, Franck Martin · 2022 · Biomedicines
  18. Palmitic Acid Induces Posttranslational Modifications of Tau Protein in Alzheimer’s Disease–Related Epitopes and Increases Intraneuronal Tau Levels
    Valeria Melissa García-Cruz, Clorinda Arias · 2024 · Molecular Neurobiology
  19. Pharmacotherapies for the Treatment of Progressive Supranuclear Palsy: A Narrative Review
    Elise E. Dunning, Boris Decourt, Nasser H. Zawia, Holly A. Shill, Marwan Noel Sabbagh · 2024 · Neurology and Therapy
  20. SON-dependent nuclear speckle rehabilitation alleviates proteinopathies
    William A. Dion, Yuren Tao, Maci Chambers, Shanshan Zhao, Riley K. Arbuckle, Michelle Sun, Syeda Kubra, Matthew A. Schaich, Yuhang Nie, Megan Ye et al. · 2025 · Nature Communications
  21. Overexpression of Tau Rescues Nogo-66-Induced Neurite Outgrowth Inhibition In Vitro
    Yuchao Zuo, Honglian Li, Nanxiang Xiong, Jianying Shen, Yizhi Huang, Peng Fu, Hongyang Zhao · 2016 · Neuroscience Bulletin
  22. Patterns of neuronal Rhes as a novel hallmark of tauopathies
    Alexander J. Ehrenberg, Kun Leng, Kaitlyn N. Letourneau, Israel Hernández, Caroline Horton Lew, William W. Seeley, Salvatore Spina, Bruce L. Miller, Helmut Heinsen, Martin Kampmann et al. · 2021 · Acta Neuropathologica
  23. Experimental Disease-Modifying Agents for Frontotemporal Lobar Degeneration
    Marcello Giunta, Eino Solje, Fabrizio Gardoni, Barbara Borroni, Alberto Benussi · 2021 · Journal of Experimental Pharmacology
  24. Therapeutic strategies for tauopathies and drug repurposing as a potential approach
    Majedul Islam, Fengyun Shen, Deepika Regmi, Deguo Du · 2022 · Biochemical Pharmacology
  25. Potential neurotoxicity of prenatal exposure to sevoflurane on offspring: Metabolomics investigation on neurodevelopment and underlying mechanism
    Jialong Jiang, Shasha Li, Yiqiao Wang, Xue Xiao, Yi Jin, Yilong Wang, Zeyong Yang, Shikai Yan, Yuanhai Li · 2017 · International Journal of Developmental Neuroscience
  26. Phase separation of the microtubule-associated protein tau
    Pijush Chakraborty, Markus Zweckstetter · 2022 · Essays in Biochemistry
  27. Quercetagitrin Inhibits Tau Accumulation and Reverses Neuroinflammation and Cognitive Deficits in P301S-Tau Transgenic Mice
    Suyue Zhong, Jinwang Ye, Yunsong Deng, Mohan Zhang, Miaozhan Zou, Xuanbao Yao, Shifeng Xiao · 2023 · Molecules
  28. Emerging roles of p300/CBP in autophagy and autophagy-related human disorders
    Yinfeng Xu, Wei Wan · 2023 · Journal of Cell Science
  29. Targeting Tau Protein with Proximity Inducing Modulators: A New Frontier to Combat Tauopathies
    Elisa Uliassi, María Laura Bolognesi, Andrea Milelli · 2025 · ACS Pharmacology & Translational Science
  30. FTLD Treatment: Current Practice and Future Possibilities
    Peter Alexander Ljubenkov, Adam L. Boxer · 2021 · Advances in experimental medicine and biology
  31. Single Posttranslational Modifications in the Central Repeat Domains of Tau4 Impact its Aggregation and Tubulin Binding
    Doris Ellmer, Manuel Brehs, Mahmood Haj‐Yahya, Hilal Ahmed Lashuel, Christian F. W. Becker · 2018 · Angewandte Chemie
  32. The hidden players: Shedding light on the significance of post-translational modifications and miRNAs in Alzheimer's disease development
    Ravinder Jit Singh, Julfequar Hussain, Amandeep Kaur, Balaji Gokul Jamdare, Deepti Pathak, Kanchan Garg, Ramanpreet Kaur, Shivani Shankar, Aditya Sunkaria · 2023 · Ageing Research Reviews
  33. A Global Multiregional Proteomic Map of the Human Cerebral Cortex
    Zhengguang Guo, Chen Shao, Yang Zhang, Wenying Qiu, Wenting Li, Weimin Zhu, Qian Yang, Yin Huang, Lili Pan, Yuepan Dong et al. · 2021 · Genomics Proteomics & Bioinformatics
  34. Tau in Alzheimer's disease: Shaping the future patient journey
    Catherine Jane Mummery, Christopher Chen Li-Hsian, Cristian A. Lasagna‐Reeves, Rik Ossenkoppele, Christopher C. Rowe, Douglas W. Scharre, Huali Wang, Simon Kyaga, Jeffrey L. Cummings · 2026 · The Journal of Prevention of Alzheimer s Disease
  35. Beyond microtubule regulation: the multifaceted roles of tau in neuronal function and dysfunction
    Lidia Bakota, Kerli Tulva, Nataliya I. Trushina, Roland Brandt · 2026 · Translational Psychiatry
  36. Small molecules targeting molecular chaperones for tau regulation: Achievements and challenges
    Chenxi He, Jinying Gu, Danni Wang, Keran Wang, Yuxuan Wang, Qidong You, Lei Wang · 2023 · European Journal of Medicinal Chemistry
  37. Sentinels of neuroinflammation: the crucial role of myeloid cells in the pathogenesis of gliomas and neurodegenerative diseases
    Blanca Cómitre-Mariano, Gabriel Vellila-Alonso, Berta Segura‐Collar, Lucía Mondéjar-Ruescas, Juan Manuel Sepúlveda-Sánchez, Ricardo Gargini · 2024 · Journal of Neuroinflammation
  38. In Silico Evaluation of Acetylation Mimics in the 27 Lysine Residues of Human Tau Protein
    Yong‐Chan Kim, Byung‐Hoon Jeong · 2019 · Current Alzheimer Research
  39. Acetylation of Aβ 40 Alters Aggregation in the Presence and Absence of Lipid Membranes
    Albert W. Pilkington, Jane E. Schupp, Morgan Nyman, Stephen J. Valentine, David M. Smith, Justin A. Legleiter · 2019 · ACS Chemical Neuroscience
  40. Chronic exercise remodels the lysine acetylome in the mouse hippocampus
    Ping Qian, Feifei Ma, Wanyu Zhang, Dingding Cao, Luya Li, Zhuo Liu, Pei Pei, Ting Zhang, Shan Wang, Jianxin Wu · 2022 · Frontiers in Molecular Neuroscience
  41. Protective effect of Gastrodia elata Blume in a Caenorhabditis elegans model of Alzheimer's disease based on network pharmacology
    Xiongfei Shi, Yuan Luo, Liping Yang, Xiaohua Duan · 2023 · Biomedical Reports
  42. Tau Phosphorylation—Much More than a Biomarker
    Sumihiro Maeda, Lennart Mucke · 2016 · Neuron
  43. Mechanistic approaches to understand the prion-like propagation of aggregates of the human tau protein
    Harish Kumar, Jayant B. Udgaonkar · 2019 · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
  44. Deciphering the Structure and Formation of Amyloids in Neurodegenerative Diseases With Chemical Biology Tools
    Isabelle Landrieu, Elian Dupré, Davy Sinnaeve, Léa El Hajjar, Caroline Smet‐Nocca · 2022 · Frontiers in Chemistry
  45. RETRACTED ARTICLE: Glimepiride mitigates tauopathy and neuroinflammation in P301S transgenic mice: role of AKT/GSK3β signaling
    Mennatallah O. Zaki, S. El-Desouky, Doaa A. Elsherbiny, Mohamed Salama, Samar S. Azab · 2022 · Inflammopharmacology · Retracted
  46. Advances in prodrug design for Alzheimer’s disease: the state of the art
    Valentin Travers--Lesage, Serge M. Mignani, Patrick Dallemagne, Christophe Rochais · 2022 · Expert Opinion on Drug Discovery
  47. Acetylated tau exacerbates apoptosis by disturbing mitochondrial dynamics in HEK293 cells
    Jun‐Fei Zhang, Zhi‐Ting Fang, Jun‐Ning Zhao, Gong‐Ping Liu, Xin Shen, Gaofeng Jiang, Qian Rong Liu · 2024 · Journal of Neurochemistry
  48. Copper Modulation and Memory Impairment due to Hippocampal Tau Pathology
    Christopher Harris, Nora E. Gray, Maya A. Caruso, Marguex Hunter, Martina Ralle, Joseph F. Quinn · 2020 · Journal of Alzheimer s Disease
  49. Development of tau-directed Small Molecule Modulators for Alzheimer’s Disease: a Recent Patent Review (2014–2018)
    Ha E Lee, Dami Lim, Jae Yeol Lee, Sang Min Lim, Ae Nim Pae · 2019 · Pharmaceutical Patent Analyst
  50. Integrated Multi-Omics Analysis of Cerebrospinal Fluid in Postoperative Delirium
    Bridget A. Tripp, Simon T. Dillon, Min Yuan, John M. Asara, Sarinnapha M. Vasunilashorn, Tamara G. Fong, Sharon K. Inouye, Long H. Ngo, Edward R. Marcantonio, Zhongcong Xie et al. · 2024 · Biomolecules
  51. The Deficits of Insulin Signal in Alzheimer’s Disease and the Mechanisms of Vanadium Compounds in Curing AD
    Jinyi Yao, Zhijun He, Guanying You, Qiong Liu, Nan Li · 2023 · Current Issues in Molecular Biology
  52. Identification of Aggregation Mechanism of Acetylated PHF6* and PHF6 Tau Peptides Based on Molecular Dynamics Simulations and Markov State Modeling
    Syed Jawad Ali Shah, Qianqian Zhang, Jingjing Guo, Hongli Liu, Huanxiang Liu, Jordi Villà­-Freixa · 2023 · ACS Chemical Neuroscience
  53. Re-Arranging the Puzzle between the Amyloid-Beta and Tau Pathology: An APP-Centric Approach
    Florence Haut, Elentina K. Argyrousi, Ottavio Arancio · 2023 · International Journal of Molecular Sciences
  54. New routes in frontotemporal dementia drug discovery
    Laura De Conti, Barbara Borroni, Marco Baralle · 2017 · Expert Opinion on Drug Discovery
  55. Succinylation Links Metabolic Reductions to Amyloid and Tau Pathology
    Yun Yang, Vı́ctor Tapias, Diana M. Acosta, Hui Xu, Huan‐Lian Chen, Ruchika P. Bhawal, Elizabeth Anderson, Elena Ivanova, Hening Lin, Botir T. Sagdullaev et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  56. Biochemical approaches to assess the impact of post-translational modifications on pathogenic tau conformations using recombinant protein
    Mohammed M. Alhadidy, Nicholas M. Kanaan · 2024 · Biochemical Society Transactions
  57. Multi‐Targeting Ligands as Prospective Therapeutics for Alzheimer's Disease, a Prevalent Neurodegenerative Disorder: Mechanistic Insights, Emerging Targets and Drug Discovery Campaigns
    Amandeep Thakur, Mandeep Rana, Sakshi Vanjani, Ke-Chi Liou, Rajeev Taliyan, Kunal Nepali, Chih‐Hao Yang · 2026 · Medicinal Research Reviews
  58. Unraveling the tau puzzle: a review of mechanistic targets and therapeutic interventions to prevent tau pathology in Alzheimer’s disease
    Sachin V Kammula, Sulagna Tripathi, Ning Wang, Valina Lynn Dawson, Ted M. Dawson, Xiaobo Mao · 2023 · Ageing and Neurodegenerative Diseases
  59. Navigating the Complexities of Traumatic Encephalopathy Syndrome (TES): Current State and Future Challenges
    Arman Fesharaki‐Zadeh · 2023 · Biomedicines
  60. Dynamics of microtubules and their associated proteins
    Eduardo Elias Benarroch · 2016 · Neurology
  61. Defining Metabolic and Nonmetabolic Regulation of Histone Acetylation by NSAID Chemotypes
    Jonathan H. Shrimp, Julie M. Garlick, Tuğsan Tezil, Alexander W. Sorum, Andrew J. Worth, Ian A. Blair, Eric M. Verdin, Nathaniel W. Snyder, Jordan L. Meier · 2017 · Molecular Pharmaceutics
  62. Deciphering the Effect of Lysine Acetylation on the Misfolding and Aggregation of Human Tau Fragment 171IPAKTPPAPK180 Using Molecular Dynamic Simulation and the Markov State Model
    Syed Jawad Ali Shah, Haiyang Zhong, Qianqian Zhang, Huanxiang Liu · 2022 · International Journal of Molecular Sciences
  63. Acetylated Tau Protein: A New Piece in the Puzzle between Brain Ischemia and Alzheimer’s Disease
    Ryszard M. Pluta, Sławomir Januszewski, Mirosław Jabłoński · 2022 · International Journal of Molecular Sciences
  64. Exploring the Role of Tau Proteins in Alzheimer’s Disease from Typical Functioning MAPs to Aberrant Fibrillary Deposits in the Brain
    Gadde Shareena, Dileep Kumar · 2023 · Springer eBooks
  65. Role of astroglia and microglia in Alzheimer's disease and multiple therapeutic interventions
    Lei Li, Ying Wang, Qilin Feng, Chaoyang Ma, Cheng He, Wenjun Wan, Lei Tang · 2025 · Journal of Alzheimer s Disease
  66. Decoding tau acetylation in Alzheimer’s disease and tauopathies: from site-specific mechanisms to therapeutic horizons
    Yoonah R. Oh, Min‐Kyoo Shin · 2025 · BMB Reports
  67. Recent advances in Alzheimer’s disease: From molecular mechanisms to therapeutic strategies
    Michelle Diane Rudman, Jason D. Ulrich, David M. Holtzman · 2026 · Cell
  68. Sports-Related Brain Injury and Neurodegeneration in Athletes
    Vipin V. Dhote, M. K. Mohan Maruga Raja, Prem Samundre, Supriya Sharma, Shraddha Anwikar, Aman Upaganlawar · 2021 · Current Molecular Pharmacology
  69. Development and characterization of novel anti-acetylated tau monoclonal antibodies to probe pathogenic tau species in Alzheimer’s disease
    Miles R. Bryan, Xu Tian, Jui‐Heng Tseng, Baggio Evangelista, Joey V. Ragusa, Audra F. Bryan, Winifred Trotman, David John Irwin, Todd J. Cohen · 2024 · Acta Neuropathologica Communications
  70. Comprehensive review on Alzheimer's disease: From the posttranslational modifications of Tau to corresponding treatments
    Xin Li, Zhisheng Ba, Juan Huang, Jianhua Chen, Jinyu Jiang, Nanqu Huang, Yong Luo · 2024 · Ibrain
  71. Role of saturated fatty acid metabolism in posttranslational modifications of the Tau protein
    Valeria Melissa García-Cruz, Roberto Coria, Clorinda Arias · 2025 · Molecular and Cellular Biochemistry
  72. Advances of therapeutic strategies for Alzheimer’s disease
    Xing Guo, Rui-zhu Yue, Zhen Cui, Shuying Wang, Tian Jia, Wenqiang Li, Wei Zhang, Linlin Shan, Chaokun Li · 2025 · Journal of Neurology
  73. Tau post-translational modifications in Alzheimer's disease: Insights into pathogenesis, therapeutic strategies, and diagnostic advances
    Hui Lei, Xiaohua Chen, Longzhu Ruan, Xuena Liu, Fei Ye, Kejing Li, Wei Cheng, Boyi Yu, Cuixia Di, Cuixia Di · 2025 · Ageing Research Reviews
  74. Tau protein: Physiological functions and multifaceted roles in neurodegenerative and psychiatric disorders
    Fei Tang, Junfen Wei, Ma-Li Wong, Peng Lei · 2025 · Genomic psychiatry :
  75. Connecting dots: Preclinical foundations to clinical realities of PDE4 inhibitors in Alzheimer's disease
    Shilpa Kumari, Kajal Bagri, Rahul R Deshmukh · 2025 · Inflammopharmacology
  76. Therapeutics Targeting Protein Acetylation Perturb Latency of Human Viruses
    Ryan J. Conrad, Mélanie Ott · 2016 · ACS Chemical Biology
  77. Aspirin for cancer is no mere antiplatelet prototype. There is potential in its ancient roots
    JAMES R. LAWRENCE, Gwendoline Joan Baxter, John R. Paterson · 2016 · Medical Hypotheses
  78. Targeting tau acetylation attenuates neurodegeneration
    Katie Kingwell · 2015 · Nature Reviews Drug Discovery
  79. Microtubule Hyperacetylation Enhances KL1-Dependent Micronucleation under a Tau Deficiency in Mammary Epithelial Cells
    Haruka Sudo · 2018 · International Journal of Molecular Sciences
  80. Effects of electroacupuncture on microglia phenotype and epigenetic modulation of C/EBPβ in SAMP8 mice
    Li Wang, Weixian Li, Wenhui Wu, Qing Liu, Min You, Xinyuan Liu, Ye Cheng, Jiangmin Chen, Qian Tan, Guangya Liu et al. · 2024 · Brain Research
  81. Acetylation Mimetic and Null Mutations Within the Filament Core of P301L Tau Have Varied Effects on Susceptibility to Seeding and Aggregation
    Ethan D. Smith, Jose Torrellas, Robert McKenna, Quan Vo, Mario Mietzsch, David Borchelt, Stefan Prokop, Paramita Chakrabarty · 2025 · Journal of Neurochemistry
  82. ACLY regulates autolysosome acidification through tubulin acetylation‐mediated assembly of V‐ATPase subunits in Alzheimer's disease model mice
    Anlan Lin, Xiaoman Dai, Jianmin Chen, Tianqing Han, Qiang Du, Minxia Wu, Jinbo Cheng, Wan‐Jin Chen, Qin-yong Ye, Xiaochun Chen et al. · 2025 · Alzheimer s & Dementia
  83. Advancement of disease-modifying therapy of Alzheimer’s disease: from the perspective of new revised criteria for diagnosis and staging of Alzheimer’s disease
    Jie Wu, Chaofan Geng, Liyang Liu, Yi Tang · 2025 · Medicine Plus
  84. Autophagy and tau protein
    Tadanori Hamano, Yoshinori Endo · 2022 · Elsevier eBooks
  85. Future Treatment of Alzheimer Disease
    Ahmet Onur Keskin, Nazlı Durmaz, Gülgün Uncu, Ebru Erzurumluoglu, Zerrin Yıldırım, Neşe Tuncer, Demet Özbabalık Adapınar · 2019 · IntechOpen eBooks
  86. SIRT1: A Novel Way to Target Tau?
    Hunter S. Futch, Cara L. Croft · 2018 · Journal of Neuroscience
  87. Advances in Alzheimer’s disease: mechanistic insights and therapeutic targets
    Yu-Juan Jia, Yi‐Jun Ge, Bowei Li, Ying Yang, Huaqiu Chen, Jie Liu, Junhong Guo, Jin‐Tai Yu, Keqiang Ye, Jian‐Zhi Wang et al. · 2026 · Science China Life Sciences
  88. An acetylated Tau-174 CSF biomarker discriminates between TDP-43 and tau pathology in patients with frontotemporal lobar degeneration
    Madison I. J. Honey, Yanaika S. Hok‐A‐Hin, Elisabeth H. Thijssen, Katheryn A Q Cousins, Babette van der Weijden, Lisanne in ‘t Veld, Erik Stoops, Sterre C.M. de Boer, Flora Hillegonde Duits, Julie F. H. De Houwer et al. · 2026 · Nature Medicine
  89. TAUCON and TAUCOM: A novel biosensor based on fluorescence resonance energy transfer for detecting tau hyperphosphorylation-associated cellular pathologies
    Sang-Hyun Ahn, Jung‐Soo Suh, Yoon‐Kwan Jang, Heonsu Kim, Kiseok Han, Yerim Lee, Gyuho Choi, Tae‐Jin Kim · 2023 · Biosensors and Bioelectronics
  90. Molecular Deformation Is a Key Factor in Screening Aggregation Inhibitor for Intrinsically Disordered Protein Tau
    Keke Chai, Jian Yang, Ying Tu, Junjie Wu, Kang Fang, Shuo Shi, Tianming Yao · 2024 · ACS Central Science
  91. Making tau amyloid models in vitro: a crucial and underestimated challenge
    Julien Broc, Clara Piersson, Yann Fichou · 2025 · FEBS Letters
  92. Hippocampal SIRT1 improves cognitive impairment by deacetylating tau protein in diabetic models
    Naihao Shi, Yuwen Lin, Binbin Yan, Xiaowei Jiao, Xiaobao Ding, Yuqing Wu, Chenghua Zhou · 2021 · European Journal of Pharmacology
  93. Sirtuin Modulation as Novel Neuroprotective Strategy for Alzheimer’s Disease
    Letizia Polito, Gloria Biella, Diego Albani · 2017 · Elsevier eBooks
  94. Mass spectrometric analysis of PTM dynamics using stable isotope labeled metabolic precursors in cell culture
    Alienke van Pijkeren, Rainer Bischoff, Marcel Kwiatkowski · 2019 · The Analyst
  95. The Lys 280 → Gln mutation mimicking disease‐linked acetylation of Lys 280 in tau extends the structural core of fibrils and modulates their catalytic properties
    Harish Kumar, Jayant B. Udgaonkar · 2021 · Protein Science
  96. Antisense Oligonucleotide-Mediated Reduction of HDAC6 Does Not Reduce Tau Pathology in P301S Tau Transgenic Mice
    Antonio Valencia, Veronica L. Reinhart Bieber, Bekim Bajrami, Galina Marsh, Stefan Hamann, Ru Wei, Karen Ling, Frank Rigo, H. Moore Arnold, Olga Golonzhka et al. · 2021 · Frontiers in Neurology
  97. Frontotemporal dementia
    Eline Wauters, Kristel Sleegers, Marc Cruts, Christine Van Broeckhoven · 2017 · Elsevier eBooks
  98. Unraveling Molecular Targets for Neurodegenerative Diseases Through Caenorhabditis elegans Models
    Rong-Mei Xu, Qiaoju Kang, Xuefei Yang, Ping Cheng Yi, Rongying Zhang · 2025 · International Journal of Molecular Sciences
  99. Neurodegeneration and aging: pathophysiology, diagnosis, and therapeutic targets
    Abhay Thakur, Rahul Sharma, Rohit R. Sharma, Anjana Devi · 2025 · Inflammopharmacology
  100. Targeted tau protein degradation: a promising therapeutic approach for tauopathies
    Narjes Baazaoui, Mohammad Yahya Alfaifi, Ali Abdullah Shati, Rania Ben Saad, Stefanıa Garzoli · 2025 · Neuroscience